How big is the Peripheral Artery Disease Market?

The Peripheral Artery Disease Market size is expected to reach USD 5.12 billion in 2024 and grow at a CAGR of 7.91% to reach USD 7.5 billion by 2029. Read More

What is the current Peripheral Artery Disease Market size?

In 2024, the Peripheral Artery Disease Market size is expected to reach USD 5.12 billion. Read More

Who are the key players in Peripheral Artery Disease Market?

Medtronic, Boston Scientific Corporation, Abbott, Edward Lifesciences and Becton, Dickinson and Company, are the major companies operating in the Peripheral Artery Disease Market. Read More

Which is the fastest growing region in Peripheral Artery Disease Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Peripheral Artery Disease Market?

In 2024, the North America accounts for the largest market share in Peripheral Artery Disease Market. Read More

What years does this Peripheral Artery Disease Market cover, and what was the market size in 2023?

In 2023, the Peripheral Artery Disease Market size was estimated at USD 4.72 billion. The report covers the Peripheral Artery Disease Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Peripheral Artery Disease Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Peripheral Artery Disease Market Size & Share Analysis - Industry Research Report

Peripheral Artery Disease Market Size & Share Analysis - Growth, Trends, and Forecasts (2024 - 2029)

The Peripheral Artery Disease Market Report is Segmented by Treatment Type (Devices and Drugs), End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers Market Sizes and Forecasts for all the Above Segments in Value (USD).

Peripheral Artery Disease Industry Overview

The peripheral artery disease market is characterized by consolidation, with major companies holding significant shares. Their dominance stems from expansive product portfolios, robust research and development capabilities, and far-reaching global distribution networks. Some of the key players in the market are Medtronic, Boston Scientific Corporation, Becton, Dickinson and Company, Abbott, and Edward Lifesciences.